Dr. Aditya Sarin

Professional Background & Philosophy

Dr. Aditya Sarin is a highly dedicated and accomplished Consultant in Medical Oncology at Sir Ganga Ram Hospital, New Delhi. As Founder of CAN HOPE TRUST and Director of ONCURA HAVEN ONCOLOGY, Dr. Sarin combines clinical excellence with a broader vision for accessible, compassionate cancer care.

With broad expertise spanning all tumor types and specialized focus on precision oncology, Dr. Sarin is recognized for his holistic approach to cancer care — integrating evidence-based treatment modalities with cutting-edge genetic and molecular profiling.

His patient care philosophy centers on compassion, transparency, and education. He believes every cancer patient deserves not only the best available medical care but also support and empathy throughout their journey. By leveraging molecular profiling and genetic testing, Dr. Sarin develops personalized treatment strategies that minimize side effects and maximize efficacy — improving both outcomes and quality of life.

Expertise & Approach

At Sir Ganga Ram Hospital, Dr. Sarin provides comprehensive oncologic care for patients with solid and hematologic malignancies. He is proficient in the latest treatment protocols including chemotherapy, immunotherapy, targeted therapy, and hormonal therapy.

Dr. Sarin's approach is deeply rooted in precision medicine — customizing treatment plans based on each patient's unique genetic and molecular tumor profile. This ensures patients receive the most effective therapies with minimal side effects.

As an integral part of a multidisciplinary team, he collaborates with radiologists, pathologists, geneticists, radiation oncologists, and surgical oncologists to formulate well-rounded, individualized treatment plans that prioritize safety, effectiveness, and ethical standards.

Educational Background & Certifications

Dr. Sarin's academic journey reflects his dedication to medical excellence and specialization in oncology:

Current Position & Leadership

Dr. Sarin currently serves in multiple leadership roles, combining clinical excellence with organizational vision:

Research Contributions & Publications

Dr. Sarin is a committed researcher with substantial contributions to oncology through clinical studies and publications. His research interests include immune response in cancer patients, early diagnostic markers, and precision medicine:

• 1

  Persistent Antibody Responses to SARS-CoV-2 Infection in Cancer Patients

  Indian Journal of Medical and Paediatric Oncology — provided critical insights into immunocompromised patient responses to COVID-19

• 2

  Reticulocyte Hemoglobin Equivalent as Early Predictor of Iron Deficiency Anemia in Cancer Patients

  Presented at major oncology conferences — demonstrates commitment to early diagnosis and improved treatment outcomes

• 3

  Comparative Study of Clinical Outcomes of Clopidogrel and Prasugrel in Patients with Acute Coronary Syndrome

  Journal of Medical Science and Clinical Research — highlights background in cardiology and internal medicine

Professional Memberships & Recognition

Dr. Sarin is an active member of several renowned oncology organizations, allowing him to stay updated on the latest research and integrate best practices into clinical work: